Lois Chandler
Chief Operating Officer bei GENE BIOTHERAPEUTICS, INC.
Profil
Lois A.
Chandler is currently the Chief Operating Officer at Taxus Cardium Pharmaceuticals Group, Inc. She previously worked as the Vice President-Product Development at Activation Therapeutics, Inc. from 2006 to 2019.
Dr. Chandler completed her undergraduate degree at Stanford University and holds a doctorate from the University of Southern California.
Aktive Positionen von Lois Chandler
| Unternehmen | Position | Beginn |
|---|---|---|
| GENE BIOTHERAPEUTICS, INC. | Chief Operating Officer | 01.07.2019 |
Ehemalige bekannte Positionen von Lois Chandler
| Unternehmen | Position | Ende |
|---|---|---|
Activation Therapeutics, Inc.
 Activation Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Part of Taxus Cardium Pharmaceuticals Group, Inc., Activation Therapeutics, Inc. develops late-stage clinical and commercial development of regenerative medicine therapeutics. | Corporate Officer/Principal | 01.01.2019 |
Ausbildung von Lois Chandler
| Stanford University | Undergraduate Degree |
| University of Southern California | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GENE BIOTHERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Activation Therapeutics, Inc.
Activation Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Part of Taxus Cardium Pharmaceuticals Group, Inc., Activation Therapeutics, Inc. develops late-stage clinical and commercial development of regenerative medicine therapeutics. | Health Technology |
